What does Healthcare Realty do and what are its main business segments?

What is Healthcare Realty's gross profit margin?

What is the revenue and EPS growth rate for Healthcare Realty year over year?

What were the key takeaways from Healthcare Realty's earnings call?

What factors drove the changes in Healthcare Realty's revenue and profit?

What were the key takeaways from Healthcare Realty’s earnings call?

What is Healthcare Realty's latest dividend and current dividend yield?

What guidance did Healthcare Realty's management provide for the next earnings period?

- **Strategic Success**: Completed $1.2B asset sales, reduced debt to 5.4x, and achieved $10M G&A savings, driving 4.8% same-store NOI growth.
- **Leasing Strength**: 82% retention, 1.3M sq.ft. pipeline, and 1,000 bps redevelopment lease gains highlight operational excellence.
- **2026 Outlook**: Flat FFO guidance ($1.61) reflects 5% core growth offset by dilution; focus on 10%+ redevelopment yields and 9%+ buyback FFO yield.
- **Discipline**: No acquisitions in base case; JV transactions require >6% IRR vs. 5.5% implied cap rate.

**【CEO Summary Section】**
- **Transformation Progress**: Completed 3-year strategic plan ahead of schedule, including $1.2 billion in asset dispositions at a 6.7% cap rate, reducing net debt to EBITDA to 5.4x, and achieving $10 million annual G&A savings.
- **Financial Results**: 2025 normalized FFO of $1.61 per share, exceeding guidance by $0.03; same-store NOI growth of 4.8%, driven by 3.1% escalators, 82% tenant retention, and 100+ basis points of occupancy gain.
- **2026 Outlook**: Guidance midpoint of $1.61 FFO, with 5% core earnings growth offsetting disposition-related dilution. Capital allocation prioritizes redevelopments (10%+ yield), buybacks (9%+ FFO yield), and accretive JVs.

**【COO Operational Update】**
- **Leasing Momentum**: 5.8M sq.ft. leased in 2025, including 1.6M sq.ft. new leases; 82% tenant retention, up 220 bps YoY; 1,000 bps lease percentage improvement at redevelopments (e.g., 64K sq.ft. St. Peter's Health deal).
- **Key Relationships**: Expanded partnerships with Hartford Healthcare (+250K sq.ft.), Baptist Health (+170K sq.ft. renewals), and Tufts Medicine (154K sq.ft. 8-year renewal).
- **Pipeline Activity**: 1.3M sq.ft. in active pipeline, with 50%+ of 2026 expirations already renewed or in process.

**【CFO Financial Commentary】**
- **Q4 2025 Results**: Normalized FFO of $0.40, FAD of $0.32; same-store cash NOI growth of 5.5%, driven by 3.7% cash spreads and 103 bps occupancy gain.
- **Balance Sheet**: Reduced debt by $900 million, extended maturities, and launched $600M commercial paper program. 2026 leverage expected to remain mid-5x.
- **2026 Guidance**: FFO $1.58-$1.64 (midpoint $1.61), same-store NOI 3.5%-4.5%, G&A $43-47M. No acquisitions or developments in base case.

**【Q&A Highlights】**
- **Same-Store NOI Drivers**: Escalators (75%+ contribution), retention (mid-80s%), absorption (expecting 100+ bps), and cash spreads (5%+ on renewals).
- **Capital Allocation**: 15%-20% maintenance CapEx; $50M buybacks in Q1, $450M remaining authorization. JV transactions require >6% IRR vs. 5.5% implied cap rate.
- **Risks**: Stock price undervaluation limits external growth; cautious on 2026 NOI deceleration (4.8% to 3.5%-4.5%).

Healthcare Realty Trust Incorporated (HR) Q4 2025 Earnings Call Transcript

- **Operational Excellence**: Same-store NOI +5.4%, occupancy 91.1%, health system leasing at 50% of activity. 
- **Strategic Dispositions**: $1.2B sold at 6.5% cap rate, with remaining pipeline targeting higher cap rates. 
- **Financial Strength**: FFO $0.41 (5% YoY), leverage 5.8x, $1B ATM and $500M buyback authorized. 
- **Growth Catalysts**: $60M redevelopment spend, 1.1M sq ft pipeline, and 3.1% escalators. 
- **Future Outlook**: Targeting $50M incremental NOI, mid-5s leverage, and selective acquisitions with $150M-$300M dry powder.

**【CEO Summary Section】**
- **Strategic Progress**: CEO highlighted investor meetings showing excitement around the strategic plan, with same-store NOI growth of 5.25% over two quarters and occupancy improving by 180 basis points. 
- **Operational Strength**: Same-store occupancy reached 91.1%, up 44 basis points sequentially, with health system leasing comprising nearly 50% of activity. 
- **Disposition Strategy**: Sold $500M in assets at a blended cap rate of 6.5%, with remaining $700M pipeline under contract. Core dispositions (high occupancy, strategic locations) achieved 5.75% cap rate, while non-core assets (legacy office, low-performing) sold at 7.25%. 
- **Balance Sheet Health**: Net debt to EBITDA reduced to 5.8x, targeting mid-5s. 
- **Future Growth**: Accelerating capital spend on redevelopment ($60M budgeted for 5 assets) and lease-up portfolio, targeting $50M incremental NOI over 3 years. 

**【COO Operations Summary】**
- **Leasing Momentum**: 1.6M sq ft executed leases, 89% tenant retention (highest in 6 years), and 3.1% annual escalators. 
- **Pipeline Strength**: 1.1M sq ft pipeline, 2/3 in LOI/lease doc phase. Demand in top 100 MSAs outstripped supply by 740K sq ft. 
- **Asset Management**: Transitioning to asset management model with 2 new hires, targeting end-of-year full conversion. 50% of new leases came from lease-up properties. 

**【CFO Financial Summary】**
- **Financial Performance**: Normalized FFO of $0.41 (5% YoY growth), same-store cash NOI up 5.4%. Payout ratio 73%. 
- **Cost Control**: G&A reduced to $9.7M, targeting $45M in 2026. 
- **Leverage Reduction**: Repaid $500M in debt, reducing leverage to 5.8x. 
- **Guidance Update**: FFO guidance raised to $1.59-$1.61, same-store NOI growth 4%-4.75%. Authorized $1B ATM and $500M buyback. 

**【Q&A Highlights】**
- **Disposition Execution**: Remaining $700M pipeline skewed to non-core assets (higher cap rates), with Richmond, VA portfolio sold at 5% cap rate. 
- **Market Dynamics**: Strong private and health system demand for outpatient medical, with bank loan rates at 4.75%. 
- **Redevelopment Strategy**: 5 assets added to pipeline, targeting $8M NOI. Focus on high-ROI projects with 9%-12% cash on cash yield. 
- **Offensive Growth**: $150M-$300M dry powder for tuck-in acquisitions, joint ventures, or strategic land purchases. 
- **Lease Economics**: 3.1% escalators, 89% retention, and 2.1% cash leasing spreads. 2027 lease roll highlighted as key risk, but 2 buildings under negotiation for extension. 
- **Balance Sheet**: 2026 bond refinancing options explored amid low spreads, with $600M maturity in August 2026.

Healthcare Realty Trust Incorporated (HR) Q3 2025 Earnings Call Transcript

- **Q2 Financial Strength**: 5.1% same-store NOI growth, 90% occupancy, and $0.41 FFO beat expectations.
- **Strategic Restructuring**: $10M+ G&A savings, new asset management platform, and 7% cap rate disposition pipeline.
- **Lease-Up Portfolio Potential**: $50M NOI upside via 70%->90% occupancy and $300M+ capital reinvestment.
- **Balance Sheet Improvement**: Mid-5x leverage target, extended debt maturities, and $1B+ asset sales.
- **Dividend Adjustment**: 23% cut to free up $100M/year for portfolio growth.


**【CEO Summary Section】**
- **Q2 Financial Highlights**: Normalized FFO of $0.41 per share (up 7% YoY), FAD of $0.33 (96% payout ratio), and same-store NOI growth of 5.1% (highest in 9 years). Occupancy rose to 90%, with 40 bps sequential increase.
- **Strategic Plan (Healthcare Realty 2.0)**: Five key initiatives include:
  1. **Governance Restructuring**: Board size reduced to 7, with 5 directors having REIT CEO experience.
  2. **Organizational Restructuring**: New asset management platform, $10M+ G&A savings, and departures of non-core staff.
  3. **Portfolio Optimization**: Segmented into stabilized (75%), lease-up (13%), and disposition (12%) portfolios. Lease-up portfolio targets $50M NOI upside via redevelopment and RTO investments.
  4. **Capital Allocation**: $300M+ allocated to lease-up portfolio over 3 years, prioritizing accretive reinvestment.
  5. **Balance Sheet Improvement**: Net debt/EBITDA expected to drop to mid-5x by year-end, with $1B+ asset sales at 7% cap rate.
- **Dividend Adjustment**: 23% reduction to $0.24/Q to free up $100M annually for portfolio reinvestment.

**【CFO Financial Commentary】**
- **Balance Sheet Enhancements**: Recast $1.5B revolver to 2030 maturity, extended term loans to 2027-2029, reducing near-term debt by $900M. Pro forma leverage at 6x, targeting mid-5x by year-end.
- **Disposition Progress**: $211M sold YTD, with $800M-$1B expected for 2025. Proceeds to deleverage and reinvest in lease-up assets.
- **Updated Guidance**: Normalized FFO raised to $1.57-$1.61 (midpoint +$0.01), driven by G&A savings and 25 bps NOI growth increase.
- **Capital Allocation**: $300M+ over 3 years for lease-up portfolio, targeting 10%+ cash-on-cash returns on redev projects.

**【Q&A Key Highlights】**
- **Lease-Up Portfolio Upside**: $50M NOI potential via 70%->90% occupancy and capital reinvestment. 10 redevelopment projects with 12-18 month timelines.
- **Disposition Impact**: $0.06 FFO dilution expected in 2026, offset by balance sheet strength and reinvestment.
- **G&A Savings**: $10M+ achieved in 2025, with $5M-$10M more from property-level efficiencies.
- **Healthcare Policy Impact**: Long-term outpatient demand drivers (site neutrality, cost efficiency) outweigh near-term regulatory uncertainty.
- **Tenant Relationships**: 1/3 of Q2 leases from health systems; focus on expanding partnerships with top tenants like HCA, Ascension, and Banner.


Healthcare Realty Trust Incorporated (HR) Q2 2025 Earnings Call Transcript

- **Strategic Priorities**: Leasing (90%+ occupancy target), asset sales ($400-500M in 2025), and balance sheet deleverage to 6.0-6.25x debt/EBITDA.
- **Leasing Momentum**: 1.5M sq ft signed Q1, 630K sq ft pipeline, 85% tenant retention driving 89.3% occupancy.
- **Financial Discipline**: Maintained $0.31 dividend; 2025 FFO guidance reaffirmed at $1.56-1.60.
- **Market Strength**: Outpatient medical demand resilient, with 3%+ rental escalators and 630K sq ft pipeline.
- **Debt Management**: Payoff $250M notes, targeting 6.0-6.25x leverage by year-end.


**【CEO Opening Remarks】**
- **Strategic Focus Areas**: Leasing (targeting 90%+ occupancy), portfolio optimization (selling underperforming assets), balance sheet management (extend debt tenor, reduce leverage), operational efficiency (lower G&A, NOI margin improvement), and financial discipline.
- **Leasing Upside**: 200-300bps of occupancy growth achievable through 2025, with 1.5M sq ft leases signed Q1.
- **Dividend Policy**: Maintained at $0.31 per share; future decisions will align with strategic plan and efficiency gains.

**【COO Leasing Update】**
- **Q1 Leasing Performance**: 1.5M sq ft leases signed, 630K sq ft pipeline (165bps of future occupancy), 370K sq ft new leases.
- **Tenant Retention**: Improved 300bps to 85%, driving 89.3% same-store occupancy.
- **Health System Demand**: 50% of pipeline from systems, driven by revenue growth and expansion plans.

**【CFO Financial Highlights】**
- **Normalized FFO**: $0.39 per share (in line with expectations), 2.3% same-store cash NOI growth.
- **Disposition Activity**: $28M in asset sales Q1, $38M from loan payoff post-quarter.
- **Debt Metrics**: Net debt/EBITDA 6.4x (unchanged from year-end), targeting 6.0-6.25x by year-end.
- **Liquidity**: $1.4B revolver capacity used to payoff $250M maturing notes.

**【Q&A Key Takeaways】**
- **Disposition Strategy**: Prioritize asset sales over JV contributions, targeting $400-500M in 2025.
- **Dividend Outlook**: Coverage to be assessed post-2025 efficiency gains; no decision until 2026.
- **Market Resilience**: Outpatient medical demand strong despite macro volatility, with 3%+ rental escalators.
- **Balance Sheet Focus**: Extend debt tenor and deleverage; no immediate buyback plans due to leverage constraints.


Healthcare Realty Trust (HR)-2 May 25-2025 Q1 Earnings call transcript

- **Record Leasing Activity**: 2 million sq ft of new leases in 2024, with Q4 at 690,000 sq ft, driving 149 bps occupancy absorption. 
- **Debt Reduction Focus**: 2025 target leverage of 6.0x–6.25x, with $400M–$500M asset sales proceeds allocated to debt repayment. 
- **Dividend Coverage**: On track for full coverage by Q4 2025, supported by 3%–3.75% same-store NOI growth. 
- **Bankruptcy Mitigation**: 80% of Steward Health space re-leased, with no revenue assumed from Prospect Medical in 2025. 
- **Operational Efficiency**: 100 bps reduction in controllable expenses, with further margin improvements expected from occupancy gains. 


**【CEO Summary Section】**
- **2024 Financial Highlights**: Normalized FFO per share of $0.40 in Q4 (2.5% YoY growth) and $1.56 for the full year. New lease commitments reached 2 million sq ft annually, with 690,000 sq ft in Q4 alone. Occupancy absorption of 149 bps for the year. 
- **Strategic Adjustments**: Accelerated debt reduction to 6.4x leverage, with $510M share buybacks and $350M debt repayment. 2025 priorities include operational efficiency, portfolio refinement, and capital allocation focused on debt reduction. 
- **Leadership Changes**: Promoted Austen Helfrich to CFO and elevated Tom Bohjalian to Independent Chair. CEO search underway with no timeline, emphasizing quality over speed. 

**【CFO Financial Commentary】**
- **2024 Financial Performance**: GAAP net income of $420M, with Non-GAAP EPS exceeding expectations. Controllable expenses reduced by 100 bps. 
- **2025 Guidance**: Same-store NOI growth of 3%–3.75%, with $400M–$500M noncore asset sales. Focus on reinvesting proceeds into debt repayment to reduce leverage to 6.0x–6.25x by year-end. 
- **Bankruptcy Management**: 80% of Steward Health square footage re-leased, with $19M in revenue secured. Assumed no revenue from Prospect Medical in 2025 guidance. 

**【Q&A Key Takeaways】**
- **Dividend Outlook**: Targeting full dividend coverage by Q4 2025 or early 2026, contingent on leasing momentum. No plans for dividend cuts. 
- **Capital Allocation**: 2025 asset sales proceeds prioritized for debt repayment, with flexibility for share buybacks if stock remains undervalued. 
- **Leasing Momentum**: Snow pipeline of 160 bps absorption visibility, with 80%–85% tenant retention expected. Dynamic leasing guidelines balance short-term rent growth with long-term stability. 
- **Debt Management**: No prepayment penalties on term loans; $250M unsecured notes maturing in May will be refinanced. 2026 maturities to be addressed in H2 2025. 


Actual											0.08	0.06	-0.03	0.13	0.1	0.17	0.1	0.07	0.08	0.04	0.08	-0.09	-0.23	-0.22	-0.18	-0.11	-0.82	-0.39	-0.26	-0.31	-0.13	-0.45	-0.17	0.04
Forecast											0.0575	0.0518	0.0721	0.1144	0.0834	0.1011	0.0957	0.1029	0.1061	0.07	0.0074	-0.114	-0.1102	-0.1269	-0.1297	-0.12	-0.113	-0.0948	-0.0526	-0.0688	-0.0838	-0.0713	-0.0223	-0.0087
Surprise	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	+39.13%	+15.83%	-141.61%	+13.64%	+19.90%	+68.15%	+4.49%	-31.97%	-24.60%	-42.86%	+981.08%	+21.05%	-108.71%	-73.36%	-38.78%	+8.33%	-625.66%	-311.39%	-394.30%	-350.58%	-55.13%	-531.14%	-662.33%	+559.77%

Actual	--	--	--	--	--	--	--	--	--	--	185.53M	178.67M	187.26M	186.96M	191.35M	188.49M	189.83M	194.25M	200.24M	140.63M	298.93M	329.40M	324.09M	329.68M	333.33M	322.08M	318.08M	308.13M	306.50M	300.06M	288.86M	287.07M	287.40M	274.73M
Forecast	--	--	--	--	--	--	--	--	--	--	179.34M	182.80M	181.39M	187.59M	189.37M	192.27M	191.56M	192.43M	197.76M	142.59M	197.15M	342.12M	329.66M	327.46M	331.80M	334.32M	323.72M	317.90M	308.28M	303.66M	298.05M	290.34M	289.60M	285.30M
Surprise	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	+3.45%	-2.26%	+3.24%	-0.34%	+1.05%	-1.96%	-0.90%	+0.95%	+1.26%	-1.37%	+51.62%	-3.72%	-1.69%	+0.68%	+0.46%	-3.66%	-1.74%	-3.07%	-0.58%	-1.18%	-3.09%	-1.13%	-0.76%	-3.70%

HR

HR fundamentals

HR Q4 2025 Earnings

Earnings Call

You can ask Aime

HR

HR fundamentals

HR Q4 2025 Earnings

Earnings Call

HR Earnings Call Summary for Q4/20259:00 AM on Feb 13, 2026

HR Earnings Call Summary for Q3/20259:00 AM on Oct 31, 2025

HR Earnings Call Summary for Q2/20259:00 AM on Aug 1, 2025

HR Earnings Call Summary for Q1/202511:00 AM on May 2, 2025

HR Earnings Call Summary for Q4/202411:00 AM on Feb 19, 2025

You can ask Aime